Page 48 - Pharma

Swedish firm Medivir inks research partnership pact with GVK Bio

Through this tie-up, the Swedish firm is aiming to increase its focus on its core research areas of oncology and infectious diseases

Dr Reddy's launches OTC hair care drug Hairootz

The company will market Hairootz through all leading departmental, pharmacy stores and online retailers

Pharma outsourcing leads healthcare BPO market in India

Indian BPO industry stands to gain from the growing demand in healthcare outsourcing, says a new Assocham-EY joint study

Aurobindo Pharma receives US FDA approval for entacapone and azithromycin

While entacapone tablet is used in the treatment of Parkinson's disease, azithromycin for injection is a macrolide antibacterial drug

CVC-led consortium buys controlling stake in $2-bn drug-maker Alvogen

The consortium of investors, which included Temasek and Vatera Healthcare, have bought Pamplona Capital's stake in Alvogen - the North America-based drug maker

Wockhardt receives US FDA nod for pain killer oxycodone

The total market for oxycodone HCl liquid in the US is about $58 million, according to IMS Health

Allergan acquire Kythera Biopharmaceuticals for $2.1 bn

This will enhance Allergan's global facial aesthetics portfolio with the addition of Kybella (deoxycholic acid) injection, used to treat submental fullness

Lonza plans a plant in Texas to make viral therapy products

The new facility is expected to develop and manufacture both viral gene therapies and virally modified cell therapies

Govt launches cluster development programme for pharma industry

The government aims to set up six pharma clusters by the end of this financial year, of which three are likely to be greenfield projects

Jubilant Life Sciences hikes Niacinamide prices by 10%

Niacin and niacinamide are forms of vitamin B3 and used in various pharmaceutical products

India and Netherlands ink pact to jointly develop vaccines

Dutch institute Intravacc will extend technical support to central PSU Bharat Immunologicals for the development of Measles-Rubella vaccine at its plant at Chola, Uttar Pradesh

US court asks Zoll to pay $23 mn to Opto Circuits

Cardiac Science Corporation, a Opto Circuit Group Company, has won nearly $23 million against Zoll in case over wearable defibrillator technology

SPARC licenses ophthalmic drug Xelpros to Sun Pharma

In addition to up-front payment of $3 million, SPARC will receive certain other milestone payments, both totalling to $16 million from Sun Pharma

Panasonic Healthcare to buy Bayer's diabetes business for Euro 1.02 bn

Bayer's diabetes care biz, with Euro 909 mn in sales in 2014, is one of the global leaders in blood glucose monitoring systems, lancing devices and diabetes management software

USFDA grants Glenmark permission to market oral contraceptive pill

The approved drug is the generic equivalent of Teva's Seasonale tablet, which achieved annual sales of approximately $53.7 million for the 12 month period ending April 2015

USFDA gives nod to Aurobindo Pharma's epileptic drug

The company received US drug regulator's approval for extended phenytoin sodium capsules - a generic version of Dilantin manaufcatured by Parke-Davis Division of Pfizer Inc

Suven Life secures patents for CNS drug in Israel, Macau and US

With these new patents, Suven has a total of five granted patents from Israel, four from Macau and 21 from US

European Commission gives nod to Merck's Sigma-Aldrich takeover deal

As part of the EU commitments, two companies have agreed to sell parts of Sigma-Aldrich's solvents and inorganics business in Europe, including a facility in Germany

Doctors Without Borders urges PM Modi not to change patent rules

MSF has launched global campaign, Hands Off!, urging India to take strong stand against the pressure from MNCs to change India's patent laws that would severely restrict production of generics

CSIR labs to develop technologies for national missions

All CSIR labs aim to become self financing in next two years